Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18,580,860
-
Total 13F shares
-
15,622,130
-
Share change
-
+62,820
-
Total reported value
-
$428,054,432
-
Put/Call ratio
-
78%
-
Price per share
-
$27.39
-
Number of holders
-
136
-
Value change
-
-$2,642,692
-
Number of buys
-
78
-
Number of sells
-
60
Institutional Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q2 2022
As of 30 Jun 2022,
OptimizeRx Corp - Common Stock (OPRX) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,622,130 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, BLAIR WILLIAM & CO/IL, Artisan Partners Limited Partnership, STATE STREET CORP, AMERICAN CENTURY COMPANIES INC, G2 Investment Partners Management LLC, Handelsbanken Fonder AB, DRIEHAUS CAPITAL MANAGEMENT LLC, and AVENIR CORP.
This page lists
136
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.